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INTRODUCTION
Underweight, overweight, and obesity in childhood and
adolescence have adverse consequences for health [1–4]. Obesity
during and after treatment of ALL may be very common, even in
patients treated on modern protocols, which do not involve cranial
radiotherapy [5]. Metabolic syndrome (MS) may also be more
common than might be expected in survivors of ALL [6,7]. A
particular concern for obesity in ALL is the possibility that it
might be associated with increased risk of relapse [8]. Under-
weight is also present in patients with ALL [9,10], and it may
also increase risk of relapse [10,11].
Several major problems exist in the literature on weight status
and MS in ALL: most studies have taken place during therapy,
with limited evidence on survivors of ALL [12–15]; almost no
evidence has been published outside the western world [6]; pub-
lished studies have generally used older deﬁnitions of under-
weight, overweight, obesity, and MS-few have used recent
international consensus deﬁnitions of unhealthy weight status
and MS.
The primary aim of the present study was therefore to examine
the prevalence of unhealthy weight status and MS in a relatively
homogenous group of survivors-in ﬁrst remission from standard
risk ALL-in Saudi Arabia. A secondary aim was to examine
whether BMI for age-based estimates of overweight and obesity
agreed with measures of over-fatness from dual-energy X ray
absorptiometry (DXA).
METHODS
Study Participants
The present study recruited standard risk patients with ALL in
ﬁrst remission, and who had been treated at King Faisal Specialist
Hospital and Research Centre on treatment Protocol Cancer Study
Group (CCG) 1891 and 1881, during the period 1994–2009.
Standard risk ALL was deﬁned as: age >1 and <10 years, initial
white blood cell count <50  109/L, DNA index 1.16 or 1.60,
lack of adverse cytogenetics/molecular genetic studies (t(9;22)/
BCR-ABL; t(1;19)/ E2A-PBX1; t (4; 11)/AF4–MLL) and nega-
tive for central nervous system or testicular involvement. Patients
were potentially eligible if they had been treated on CCG 1891
and 1881 and were in ﬁrst remission (n ¼ 77). This treatment
protocol did not involve cranial radiotherapy. Patients were
ineligible if they had relapsed (n ¼ 3), were pregnant (n ¼ 2),
had pre-existing type 1 diabetes (before diagnosis of ALL)
(n ¼ 1) or had a longbone fracture in plaster (n ¼ 2), leaving
69 potentially eligible survivors. The rationale for the exclusions
was to leave a sample to which abnormalities in weight status or
body composition might be attributable to ALL or its treatment.
All 69 eligible survivors were invited to participate, but 56 (81%)
agreed to take part in the present study. The sample of 56 patients
was similar to the sample of 69 eligible for age at diagnosis, and
for sex distribution, though the small number of those who did not
consent precluded statistical analysis.
Ethics committee approval was provided by the Research
Advisory Council (RAC) at King Faisal Specialist Hospital and
Research Centre on 26 October 2009. Study participants provided
informed written consent to their participation.
Background. This study estimated prevalence of unhealthy
weight status and metabolic syndrome (MS) amongst Saudi survi-
vors of standard risk ALL. Procedure. We recruited 56 survivors,
mean age 13.4 years (SD 4.1), a mean of 9.1 years (SD 4.1) post-
diagnosis. The BMI for age was used to deﬁne weight status relative
to national (Saudi) and international (Cole et al., Cole-IOTF, WHO,
and CDC) reference data. We measured body composition by dual-
energy X-ray absorptiometry (DXA), waist circumference, blood
pressure, lipid proﬁle (HDL-C, Triglycerides), fasting glucose and
insulin. Results. According to international deﬁnitions based on
BMI for age, around half of the sample had unhealthy weight status.
All of the approaches based on BMI for age underestimated over-
fatness, present in 27/51 (53%) of the sample according to DXA.
Prevalence of MS was 7.1% (3/42 of those over 9-years old) and
5.4% (3/56) by applying the International Diabetes Federation (IDF)
deﬁnition and National Cholesterol Education Program Third Adult
Treatment panel Guidelines (NCEP III), respectively. However, MS
by the NCEP III deﬁnition was present in 19% of the overweight and
obese survivors and 7.1% of the sample had at least two of the
components of MS. Conclusion. Unhealthy body weight and over-
fatness may be common amongst adolescent Saudi survivors of
standard risk ALL, though overweight and obesity may be no
more common than in the general Saudi adolescent population.
Deﬁning weight status using BMI underestimates overfatness.
Ideally, body composition and cardiometabolic risk factors should
be monitored at late effects clinics. Pediatr Blood Cancer 2012;59:
133–137.  2011 Wiley Periodicals, Inc.
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Anthropometric Data
Height and weight were measured to 0.1 cm and 0.1 kg,
respectively, using a Scale-Tronix 5002 stand on scale while
patients removed shoes and outdoor clothes. The BMI was calcu-
lated and expressed as an age and sex speciﬁc z-score or centile.
Classification of Weight Status
In the present study, we used the most modern, recommended
deﬁnitions of body weight status based on BMI for age. Saudi
BMI reference data are available [16] in the form of centile charts
for boys and girls and so these were used in the present study.
Various international BMI for age reference data are also avail-
able, the most widely used probably those provided by WHO [17]
and the US Centers for Disease Control and Prevention (CDC)
[18], so both of these were also used in the present study. BMI
z-scores were calculated from WHO 2007 reference data using
WHO Anthro version 3.2.2, January 2011 software [19]. BMI
z-scores were calculated relative to US CDC reference data
[18]. When using Saudi, WHO, and US CDC BMI for age
reference data obesity was deﬁned conventionally, as95th centile,
overweight as 85th to 94th centile, and underweight as <5th
percentile [18,20,21].
In recent years, the Cole-International Obesity Task Force
(IOTF) BMI [22] based deﬁnitions of pediatric overweight and
obesity have become popular [23]: these facilitate international
comparisons of obesity prevalence and use age and sex speciﬁc
cut-offs for absolute BMI. We therefore also deﬁned overweight
and obesity in participants in the present study using the
Cole-IOTF approach. More recently, Cole et al. [24] proposed
an international deﬁnition of pediatric underweight based on
BMI for age and so we used this to deﬁne underweight [24].
Body Composition Measures
A recent systematic review [23] concluded that the BMI
for age is a helpful simple proxy for excessive body fatness.
However, the BMI may not be as informative as measurement
of body composition in pediatrics in general, including studies
of survivors of childhood cancer [25,26]. In addition, body com-
position is recommended by the International Diabetes Federation
(IDF) as a useful research measure, which is relevant to deﬁning
MS [27]. In the present study, we therefore measured body com-
position (% body fat) in participants by DXA as recommended
by Warner et al. [25] using DXA Lunar Prodigy software version
9.15.
Levels of total body fat % which are excessive (because of
associations with adverse cardiometabolic risk proﬁles) have been
established by previous studies as: >25% fat for males and >30%
for females age 5–18 years, >25% and >32% in males and
females aged over 18 years [28] and so these deﬁnitions were
applied in the present study.
Metabolic Syndrome: Definitions and Measurements
We deﬁned the presence or absence of the MS in all partic-
ipants using two modern and widely accepted deﬁnitions: the IDF
approach [29] and the approach of The National Cholesterol
Education Program Third Adult Treatment Panel guidelines
(NCEP III) modiﬁed by Cook et al. [30].
MS in 10–15 years was deﬁned by the IDF as having central
obesity assessed by Waist circumference (WC) 90th centile plus
two or more of the following criteria: triglycerides 150 mg/dl;
HDL-cholesterol < 40 mg/dl blood pressure 130/85 mm Hg;
fasting glucose 100 mg/dl. For those age 16 years, MS was
deﬁned by the IDF as having central obesity assessed by WC
94 cm for men and WC 80 cm for women plus two or
more of the following criteria: triglycerides 150 mg/dl; HDL-
cholesterol < 40 mg/dl in males and <50 mg/dl for females;
Blood pressure 130/85 mm Hg; fasting glucose 100 mg/dl.
The NCEP III approach to deﬁning MS for those aged 10–19
years requires at least three of the following ﬁve criteria:
(i) central obesity, WC 90th centile; (ii) triglycerides
110 mg/dl; (iii) HDL-cholesterol 40 mg/dl; (iv) blood
pressure 90th centile; (v) fasting glucose  110 mg/dl.
For those 19 years three criteria are required from the
following: (i) central obesity assessed by WC 102 cm for men
and WC 88 cm for women; (ii) triglycerides 150 mg/dl;
(iii) HDL-cholesterol  40 mg/dl for men and HDL-cholesterol
50 mg/dl for women; (iv) blood pressure 130/85 mm Hg;
(v) fasting glucose 110 mg/dl.
In order to apply these two approaches to deﬁning the MS a
single trained observer measured abdominal obesity by WC at
4 cm above the umbilicus [31], blood pressure, triglycerides,
fasting glucose. We interpreted these in the age and sex speciﬁc
ways recommended by the IDF [29] and by the NCEP [30]. In
addition, we calculated the prevalence of 1 and 2 components of
the MS by both deﬁnitions.
Statistical Analysis, Power, and Sample Size
Power of the present study was ﬁxed by the size of the cohort
of patients available to us, who had been treated on protocol CCG
1891. The sample size was similar to or larger than many previous
studies of weight status in ALL [6,32–34].
Means and standard deviations are presented in the results
unless otherwise stated. Normality of data was tested by using
formal Normality tests. A P-value of < 0.05 was considered as
signiﬁcant. Minitab 15.1.30.0 software was used for all statistical
analyses except for the weighted kappa analysis, which used
Medcalc software version 11.5.0.0. Differences between groups
were tested for statistical signiﬁcance by using two sample t-tests.
Two proportion tests were applied to test the signiﬁcance of
differences between two proportions.
The weighted Kappa statistic (k) with 95% CI was used to
assess the degree of agreement between the different approaches
to deﬁning underweight, healthy weight, overweight, obesity, and
overfatness. We also used the weighted kappa analysis as a pre-
liminary test of agreement between the two deﬁnitions of pediat-
ric MS. The k statistics were interpreted as recommended by
Landis and Koch [35]: ‘‘slight agreement’’ 0.0–0.20; ‘‘fair agree-
ment’’ 0.21–0.40; ‘‘moderate agreement’’ 0.41–0.60; ‘‘substantial
agreement’’ 0.61–0.80; ‘‘almost perfect agreement’’ 0.81–1.00.
RESULTS
Characteristics of Study Participants
The sample of 56 consented to all measures, though ﬁve
did not attend for DXA measurements. Mean (SD) time from
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diagnosis was 9.1 (4.1) years, and mean time from end of therapy
was 6.2 (3.9) years. Characteristics of study participants are
shown in Table I.
Weight Status of the Sample
Weight status of the sample is illustrated in Table II. Approxi-
mately half of the sample was of unhealthy weight status (under-
weight, overweight, obese) by most of the approaches used to
deﬁne weight status, though prevalence of unhealthy weight status
varied by the approach taken. In particular, the prevalence of
overweight and obesity was lower when using the local Saudi
BMI reference data (prevalence 21.4%; 12/56 participants) than
when using the alternative deﬁnitions (prevalence of combined
overweight and obesity varied between 28.6% and 32.1% for the
other deﬁnitions). Underweight was present in the sample, with
prevalence varying differing slightly between the different deﬁ-
nitions, as illustrated in Table II.
Agreement Between Different Approaches to Defining
Weight Status
Agreement between the different deﬁnitions based on BMI for
age, using weighted Kappa (k) statistics, was ‘‘moderate-substan-
tial’’ between use of the Saudi reference data and deﬁnitions
versus those from the US CDC (k ¼ 0.70) and WHO
(k ¼ 0.67). There was poorer agreement between the Saudi ap-
proach and the Cole et al. [24] and Cole-IOTF [22] approaches to
deﬁning weight status (k ¼ 0.47).
Body Composition of the Sample
According to DXA estimates of body fatness, more than half
of the sample (52.9%, 27 out of 51 survivors) had over-fatness.
Mean (SD) body fat % by using DXA was 24.7% (SD 10.6) for
males and 37.6% (SD 8.8) for females (P <0.001).
When the ability of the various anthropometric approaches
(with reference data from Saudi Arabia, the US CDC, the WHO
and the Cole-IOTF approach) to deﬁning overweight and obesity
based on BMI for age was compared against the measures of
overfatness by DXA (Table III), agreement was only fair [35].
Metabolic Syndrome
Prevalence of MS was 7.1% (3/42 survivors aged 10 years)
by the IDF deﬁnition [29] and 5.4% (3 out of 56) by the NCEP
approach [30]. Of the three survivors deﬁned as having MS by the
IDF deﬁnition, two survivors were also deﬁned as having MS
using the NCEP deﬁnition. The weighted kappa statistic for agree-
ment between the two methods was 0.65, indicating ‘‘substantial
agreement’’, but with a wide conﬁdence interval (95% CI: 0.19–
1.00). In those survivors who were overweight or obese (BMI at
or above the 85th centile relative to CDC reference data) preva-
lence of MS was much higher (19% by the NCEP III criteria).
Prevalence of 1 MS component was 35.7% (15/42) using the
IDF criteria, and 37.5% (21/56) using the NCEP III criteria.
Prevalence of 2 MS components was 11.9% (5 /42) using the
IDF criteria and 7.1% (4/56) using the NCEPIII criteria.
DISCUSSION
In the present study, around half of the adolescent survivors of
standard risk ALL had unhealthy weight status (underweight,
overweight, or obesity) by applying the international approaches
based on BMI, an average of 6 years after completion of chemo-
therapy. Prevalence of excessive body fatness measured by DXA
was very high, and much higher than the BMI for age-based
deﬁnitions of overweight and obesity suggested. It is likely that
TABLE I. Characteristics of Study Participants Mean (SD)
Males Females Total sample
(n ¼ 34) (n ¼ 22) (n ¼ 56)
Age (years) 13.0 (4.6) 14.0 (3.1) 13.4 (4.1)
Height (m) 1.49 (0.20) 1.51 (0.11) 1.50 (0.17)
Weight (kg) 42.0 (16.9) 49.3 (18.4) 46.7 (17.5)
Time from diagnosis (years) 9.1 (4.5) 9.1 (3.2) 9.1 (3.2)
Time since completion of therapy (years) 5.9 (4.5) 6.7 (3.1) 6.2 (3.9)
CDCa BMI-z score 0.17 (1.6) 0.16 (1.3) 0.04 (1.48)
WHOb BMI-z score 0.14 (2.0) 0.31 (1.5) 0.21 (1.77)
% body fat by DXAc 24.7 (10.6) 37.6 (8.8) 29.2 (11.7)
aCDC, US Centers for Disease Control and Prevention. bWHO, World Health Organisation. cDXA, dual-energy X-ray absorptiometry.
TABLE II. Prevalence of Obesity, Overweight, and Underweight by Four Methods
Reference approaches Obesity (n), % Overweight (n) % Underweight (n), %
Saudi reference data [16] (4) 7.1 (8) 14.3 (5) 8.9
Cole et al. and Cole-IOTFa; [22,24] (5) 8.9 (13) 23.2 (12) 21.4
CDCb [18] (6) 10.7 (10) 17.9 (10) 17.9
WHOc [17] (6) 10.7 (12) 21.4 (7) 12.5
aCole-IOTF, Cole-International Obesity Task Force. bCDC, US Centers for Disease Control and Prevention. cWHO, World Health Organisation.
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BMI-based approaches to deﬁning overweight and obesity will
underestimate the scale of the problem in survivors of ALL.
The optimal population reference data (for BMI for age or for
body fatness) on which to base estimates of unhealthy body
weight is unclear, though one common view is that such
reference data should have been collected prior to the obesity
epidemic. Data collected prior to the obesity epidemic might
represent ‘‘standards’’. More recently collected data might
describe norms characterised by a higher prevalence of unhealthy
weight status [36].
While prevalence of underweight, overfatness, overweight,
and obesity seemed high in the present study, comparison with
recent Saudi population data is necessary to establish if this as an
ALL-speciﬁc problem or if it simply reﬂects the nutritional status
of contemporary Saudi adolescents. El Mouzan et al. [20] provide
a healthy population-based comparison group for the present
study. This survey of 19,317 Saudi children and adolescents,
which deﬁned overweight and obesity as BMI for age >85th
and > 95th centiles, respectively relative to Saudi reference
data for BMI for age [16], found that 34.4% of the children and
adolescents were overweight or obese (combined). The preva-
lence of BMI for age deﬁned overweight and obesity in the
adolescent survivors of ALL in the present study (combined
28.5%) was actually lower than in the general population in
Saudi Arabia, suggesting that overweight and obesity observed
is probably not an ALL speciﬁc problem. Further research on the
causes of obesity in ALL and the general population in Saudi
Arabia would be desirable. We are not aware of any etiological
studies of adolescent obesity in Saudi Arabia-studies to date
have focused on describing the rapid recent increases in obesity
prevalence [20,21].
While MS was not common in the present study, prevalence of
1 and 2 components of MS were higher. We are not aware of any
comparable studies of prevalence of MS for the general adoles-
cent population in Saudi Arabia, and so further research would be
required to establish whether or not the prevalence estimates
observed in the present sample were high or low.
Relatively few other studies have focused on medium term
survivors of ALL and we have been unable to ﬁnd any reports
of weight status, body composition, or MS (with modern deﬁni-
tions) in survivors of ALL treated on modern protocols outside
western countries [12,34].Warner et al. [25] found that the BMI
for age provided a poor indicator of excess adiposity in patients
with childhood cancer and other chronic diseases, consistent with
the ﬁndings of the present study.
The present study was limited by small sample size, but the
sample recruited was similar to or larger than a number of
previous studies in this area [6,32–34] and was fairly homogenous,
in that all participants were survivors of standard risk childhood
ALL on the same treatment protocol. Another limitation was the
short time between end of the therapy and the present study.
Longer-term follow-up studies would be useful, and the high
prevalence of both overfatness and unhealthy body weight status
observed in the present study indicates that longer-term follow-up
studies of survivors of ALL outside the Western world are
indicated. While contemporary Saudi data were available on
prevalence of overweight and obesity using the BMI for age, no
Saudi data were available for body fatness measured by DXA and
so a population comparison group was not available for body
fatness.
CONCLUSIONS
Unhealthy body weight status and unhealthy body composition
appear to be quite common among the medium-term survivors
of standard-risk ALL in Saudi Arabia, though overweight and
obesity may be no more common than in the general population.
Use of BMI for age-based deﬁnitions of overweight and obesity
will underestimate the prevalence of overfatness, and so body
composition measurement should be considered. Future care of
long-term survivors of ALL should include assessment of weight
status, should consider body composition measurement rather
than just measures of BMI, and should consider cardiometabolic
health.
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